Bernard Kwabi-Addo

Bernard Kwabi-Addo is a cancer biologist and a lecturer. He is an Associate Professor of Biochemistry at Howard University in Washington D.C. He graduated from Queen Mary & Westfield College, University of London (where he received a PhD studying site-directed gene targeting in mammalian cells using the bacteriophage Cre-loxP recombination system as a tool), University College London and Dundee University (Scotland). Dr. Kwabi-Addo trained at the Baylor College of Medicine in Cancer biology specifically in prostate cancer research. His laboratory research focuses on identifying aberrant epigenetic changes associated with prostate cancer etiology/progression with the ultimate goal to discover novel biomarkers for the disease detection/progression. He has published scientific articles in journals including Nature Genetics, PNAS, Cancer Research, Prostate and Epigenetics. He lives in Virginia with his wife, Gertrude, a financial analyst, and with his three sons, Benjamin, Joshua and David.